Rajesh Shrotriya

Insider Reports History

Entity
Individual
Location
157 Technology Drive, Irvine, CA
Signature
/s/ Rajesh Shrotriya
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajesh Shrotriya:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. Director Option to purchase Common Stock 500K Jan 27, 2023 Direct
CASI Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 346K May 25, 2022 Direct

Insider Reports Filed by Rajesh Shrotriya

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTBP GT Biopharma, Inc. Jan 27, 2023 1 $0 4 Feb 1, 2023 Director
GTBP GT Biopharma, Inc. Jul 15, 2022 3 $0 4 Jul 19, 2022 Director
CASI CASI Pharmaceuticals, Inc. May 25, 2022 1 $0 4 May 26, 2022 Director
CASI CASI Pharmaceuticals, Inc. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
GTBP GT Biopharma, Inc. Feb 16, 2021 1 $0 4 Feb 14, 2022 Director
GTBP GT Biopharma, Inc. Jan 13, 2021 0 $0 3 Feb 14, 2022 Director